Related Experiment Video

Updated: May 4, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

13.9K

Therapeutic targeting of EPH receptors and their ligands

Andrew W Boyd1, Perry F Bartlett2, Martin Lackmann3

  • 1Leukaemia Foundation Research Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4029, Australia.

Nature Reviews. Drug Discovery
|January 1, 2014
PubMed

Insights

EPH receptor-ephrin signaling plays critical roles in chronic diseases and nerve regeneration. Therapeutic targeting shows promise for cancer and non-malignant conditions, with ongoing clinical development.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Drug discovery

Background:

  • EPH receptor (EPH)-ephrin signaling is crucial in various chronic and regenerative diseases.
  • The roles of EPHs and ephrins in tumor progression and nerve injury are extensively studied.
  • This signaling pathway is a key focus in understanding disease mechanisms.

Purpose of the Study:

  • To review the critical roles of EPH-ephrin signaling in disease.
  • To discuss therapeutic targeting strategies for EPH-ephrin pathways.
  • To highlight progress and challenges in drug discovery for these targets.

Main Methods:

  • Literature review of EPH-ephrin signaling in disease.
  • Analysis of preclinical and clinical data for therapeutic agents.
  • Discussion of drug development challenges and limitations.

Main Results:

  • EPH-ephrin signaling is implicated in tumor growth and nerve regeneration.
  • Several anticancer agents targeting EPHs are in clinical trials.
  • Preclinical data supports the development of therapies for non-malignant diseases.

Conclusions:

  • EPH-ephrin signaling represents a promising area for therapeutic intervention.
  • Significant progress has been made in developing targeted therapies.
  • Further research and development are needed to overcome challenges in clinical application.

More Related Videos

Dissection and Culture of Mouse Embryonic Kidney08:30

Dissection and Culture of Mouse Embryonic Kidney

Published on: May 17, 2017

11.4K
Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites05:28

Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites

Published on: June 2, 2023

3.1K

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K